28.09.2012 • News

Songwon Announces Expansion of DOTO Manufacturing Capacity

Songwon Industrial Group is announcing the expansion of DOTO (Di-n-Octyltin Oxide) production capacity by 60% at its Ulsan (Korea) manufacturing facility with the project completion expected mid 2013.

The new DOTO capacity will come at the expense of a reduction in DBTO (Di-n-Butyltin Oxide) capacity. Beyond the current project, Songwon is planning additional DOTO capacity to support future market needs.

REACH (the Registration, Evaluation, Authorisation and Restriction of Chemical substances) is the European Community Regulation on chemicals and their safe use (EC 1907/2006). Since its implementation in 2007, REACH and other global environmental regulation initiatives have become stricter. As a result the movement to replace Butyltin compounds is accelerating, especially in the European market. Songwon foresees that where possible, Butyltin compounds will be replaced by Octyltin compounds by 2015. The market demand shifting from DBTO to DOTO is the driving force behind Songwon's decision to realign manufacturing to reflect the market needs.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read